Design of a multiepitope immunotherapy for fish allergy

design-of-a-multiepitope-immunotherapy-for-fish-allergy
Design of a multiepitope immunotherapy for fish allergy

References

  1. Sharp, M. F. & Lopata, A. L. Fish allergy: in review. Clin. Rev. Allergy Immunol. 46, 258–271. https://doi.org/10.1007/s12016-013-8363-1 (2014).

    Google Scholar 

  2. Sicherer, S. H. & Sampson, H. A. Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J. Allergy Clin. Immunol. 141, 41–58. https://doi.org/10.1016/j.jaci.2017.11.003 (2018).

    Google Scholar 

  3. Taylor, S. L. & Hefle, S. L. Food allergen labeling in the USA and Europe. Curr. Opin. Allergy Clin. Immunol. 3, 186–190. https://doi.org/10.1097/01.all.0000225158.75521.ad (2006).

    Google Scholar 

  4. Sampson, H. A. Update on food allergy. J. Allergy Clin. Immunol. 113, 805–819. https://doi.org/10.1016/j.jaci.2004.03.014 (2004).

    Google Scholar 

  5. Yang, Y. et al. An overview of seafood allergens: Structure–Allergenicity relationship and allergenicity elimination processing techniques. Foods 14, 2241. https://doi.org/10.3390/FOODS14132241 (2025).

    Google Scholar 

  6. Sudharson, S., Kalic, T., Hafner, C. & Breiteneder, H. Newly defined allergens in the WHO/IUIS allergen nomenclature database during 01/2019-03/2021. Allergy 76, 3359–3373. https://doi.org/10.1111/ALL.15021 (2021).

    Google Scholar 

  7. Sun, Y. et al. Fish allergy: A review of clinical Characteristics, Mechanism, Allergens, Epitopes, and Cross-Reactivity. ACS Food Sci. Technol. 4, 304–315. https://doi.org/10.1021/acsfoodscitech.3c00572 (2024).

    Google Scholar 

  8. Zieglmayer, P. et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine 11, 43–57. https://doi.org/10.1016/J.EBIOM.2016.08.022 (2016).

    Google Scholar 

  9. Cezmi, A. & Akdis Mübeccel Akdis. Advances in allergen immunotherapy: aiming for complete tolerance to allergens. Sci. Transl Med. https://doi.org/10.1126/scitranslmed.aaa7390 (2015).

    Google Scholar 

  10. Verhoef, A., Alexander, C., Kay, A. B. & Larché, M. T cell epitope immunotherapy induces a CD4 + T cell population with regulatory activity. PLoS Med. 2, 0253–0261. https://doi.org/10.1371/JOURNAL.PMED.0020078 (2005).

    Google Scholar 

  11. Noriega, D. B., Teodorowicz, M., Savelkoul, H. & Ruinemans-Koerts, J. The basophil activation test for clinical management of food allergies: recent advances and future directions. J. Asthma Allergy. 14, 1335–1348. https://doi.org/10.2147/JAA.S237759 (2021).

    Google Scholar 

  12. Kuehn, A., Swoboda, I., Arumugam, K., Hilger, C. & Hentges, F. Fish allergens at a glance: variable allergenicity of parvalbumins, the major fish allergens. Front. Immunol. 5 (APR), 79259. https://doi.org/10.3389/FIMMU.2014.00179/XML (2014).

    Google Scholar 

  13. Rawat, S. S., Keshri, A. K., Kaur, R. & Prasad, A. Immunoinformatics approaches for vaccine design: A fast and secure strategy for successful vaccine development. Vaccines 11. https://doi.org/10.3390/vaccines11020221 (2023).

  14. Villanueva-Flores, F., Sanchez-Villamil, J. I. & Garcia-Atutxa, I. AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development. Npj Vaccines 2025. 10, 1. https://doi.org/10.1038/s41541-025-01258-y (2025).

    Google Scholar 

  15. De Groot, A. S. & Martin, W. Reducing risk, improving outcomes: bioengineering less Immunogenic protein therapeutics. Clin. Immunol. 131, 189–201. https://doi.org/10.1016/j.clim.2009.01.009 (2009).

    Google Scholar 

  16. Larsen, M. V. et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinform. 8, 1–12. https://doi.org/10.1186/1471-2105-8-424/TABLES/3 (2007).

    Google Scholar 

  17. Stranzl, T., Larsen, M. V., Lundegaard, C., Nielsen, M. & NetCTLpan Pan-specific MHC class I pathway epitope predictions. Immunogenetics 62, 357–368. https://doi.org/10.1007/S00251-010-0441-4 (2010).

    Google Scholar 

  18. Kaabinejadian, S. et al. Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Front. Immunol. 13. https://doi.org/10.3389/FIMMU.2022.835454/PDF (2022). MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant.

  19. Saha, S. & Raghava, G. P. S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins: Struct. Function Genet. 65, 40–48. https://doi.org/10.1002/PROT.21078 (2006).

    Google Scholar 

  20. Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8. https://doi.org/10.1186/1471-2105-8-4 (2007).

  21. Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2 – A server for in Silico prediction of allergens. J. Mol. Model. 20. https://doi.org/10.1007/s00894-014-2278-5 (2014).

  22. Rathore, A. S., Choudhury, S., Arora, A., Tijare, P. & Raghava, G. P. S. ToxinPred 3.0: an improved method for predicting the toxicity of peptides. Comput. Biol. Med. 179. https://doi.org/10.1016/j.compbiomed.2024.108926 (2024).

  23. Bui, H. H. et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinform. 7, 153. https://doi.org/10.1186/1471-2105-7-153 (2006).

    Google Scholar 

  24. Gasteiger, E. et al. The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784–3788. https://doi.org/10.1093/nar/gkg563 (2003).

    Google Scholar 

  25. Abramson, J. et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature 630, 493–500. https://doi.org/10.1038/s41586-024-07487-w (2024).

    Google Scholar 

  26. Heo, L., Park, H., Seok, C. & GalaxyRefine Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41. https://doi.org/10.1093/nar/gkt458 (2013).

  27. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283–291. https://doi.org/10.1107/s0021889892009944 (1993).

    Google Scholar 

  28. Vajda, S. et al. New additions to the ClusPro server motivated by CAPRI. Proteins: Structure, Function and Bioinformatics. ;85:435–44. (2017). https://doi.org/10.1002/prot.25219

  29. Desta, I. T., Porter, K. A., Xia, B., Kozakov, D. & Vajda, S. Performance and its limits in rigid body Protein-Protein Docking. Structure 28, 1071–1081e3. https://doi.org/10.1016/j.str.2020.06.006 (2020).

    Google Scholar 

  30. Jones, G. et al. Elucidation of protein function using computational Docking and hotspot analysis by cluspro and ftmap. Acta Crystallogr. D Struct. Biol. 78, 690–697. https://doi.org/10.1107/S2059798322002741 (2022).

    Google Scholar 

  31. Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859–1865. https://doi.org/10.1002/jcc.20945 (2008).

    Google Scholar 

  32. Huang, J. & Mackerell, A. D. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135–2145. https://doi.org/10.1002/jcc.23354 (2013).

    Google Scholar 

  33. Abraham, M. J. et al. Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001 (2015).

    Google Scholar 

  34. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38. https://doi.org/10.1016/0263-7855(96)00018-5 (1996).

    Google Scholar 

  35. Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology Meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 5. https://doi.org/10.1371/journal.pone.0009862 (2010).

  36. Grote, A. et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33. https://doi.org/10.1093/nar/gki376 (2005).

  37. Elliott, S. L. et al. Phase I trial of a CD8 + T-cell peptide epitope-based vaccine for infectious mononucleosis. J. Virol. 82, 1448–1457. https://doi.org/10.1128/JVI.01409-07 (2008).

    Google Scholar 

  38. Rappuoli, R. & Aderem, A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473, 463–469. https://doi.org/10.1038/NATURE10124 (2011).

    Google Scholar 

  39. Mora, M., Veggi, D., Santini, L., Pizza, M. & Rappuoli, R. Reverse vaccinology. Drug Discov Today. 8, 459–464. https://doi.org/10.1016/S1359-6446(03)02689-8 (2003).

    Google Scholar 

  40. Kanampalliwar, A. M. Reverse vaccinology and its applications. Methods Mol. Biol. 2131, 1–16. https://doi.org/10.1007/978-1-0716-0389-5_1 (2020).

    Google Scholar 

  41. Meloen, R. H., Langeveld, J. P. M., Schaaper, W. M. M. & Slootstra, J. W. Synthetic peptide vaccines: Unexpected fulfillment of discarded hope? In: Biologicals. Academic Press; pp. 233–6. (2001). https://doi.org/10.1006/biol.2001.0298

  42. Pereira, B. et al. Prevalence of sensitization to food allergens, reported adverse reaction to foods, food avoidance, and food hypersensitivity among teenagers. J. Allergy Clin. Immunol. 116, 884–892. https://doi.org/10.1016/j.jaci.2005.05.047 (2005).

    Google Scholar 

  43. Jędrychowski, L. & Wichers, H. J. Chemical and biological properties of food allergens. Chem. Biol. Prop. Food Allergens. 1–429. https://doi.org/10.1201/9781420058574 (2009).

  44. Zuidmeer-Jongejan, L. et al. Development of a hypoallergenic Recombinant parvalbumin for First-in-Man subcutaneous immunotherapy of fish allergy. Int. Arch. Allergy Immunol. 166, 41–51. https://doi.org/10.1159/000371657 (2015).

    Google Scholar 

  45. Yuen, R., Kuniholm, J., Lisk, C. & Wetzler, L. M. Neisserial PorB immune enhancing activity and use as a vaccine adjuvant. Hum. Vaccin Immunother. 15, 2778–2781. https://doi.org/10.1080/21645515.2019.1609852 (2019).

    Google Scholar 

  46. Li, M., Jiang, Y., Gong, T., Zhang, Z. & Sun, X. Intranasal vaccination against HIV-1 with adenoviral Vector-Based nanocomplex using synthetic TLR-4 agonist peptide as adjuvant. Mol. Pharm. 13, 885–894. https://doi.org/10.1021/acs.molpharmaceut.5b00802 (2016).

    Google Scholar 

  47. Prickett, S. R., Rolland, J. M. & O’Hehir, R. E. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy. Clin. Exp. Allergy. 45, 1015–1026. https://doi.org/10.1111/CEA.12554 (2015).

    Google Scholar 

  48. Chen, X., Zaro, J. L. & Shen, W. C. Fusion protein linkers: Property, design and functionality. Adv. Drug Deliv Rev. 65, 1357–1369. https://doi.org/10.1016/j.addr.2012.09.039 (2013).

    Google Scholar 

  49. Sircar, G., Jana, K., Dasgupta, A., Saha, S. & Bhattacharya, S. G. Epitope mapping of Rhi o 1 and generation of a hypoallergenic variant: A CANDIDATE MOLECULE FOR FUNGAL ALLERGY VACCINES. J. Biol. Chem. 291, 18016. https://doi.org/10.1074/JBC.M116.732032 (2016).

    Google Scholar 

  50. Solomon, J. S. et al. Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis Japonica. Protein Expr Purif. 36, 226–231. https://doi.org/10.1016/j.pep.2004.04.011 (2004).

    Google Scholar 

  51. Gasteiger, E. et al. Protein identification and analysis tools on the expasy server. In: The Proteomics Protocols Handbook. Humana; 571–607. https://doi.org/10.1385/1-59259-890-0:571. (2005).

  52. Karp, C. L. et al. Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries. Vaccine 33, 3471–3479. https://doi.org/10.1016/j.vaccine.2015.05.071 (2015).

    Google Scholar 

  53. Mandal, S., Chanu, W. P. & Natarajaseenivasan, K. Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach. Front. Immunol. 16, 1442101. https://doi.org/10.3389/FIMMU.2025.1442101/BIBTEX (2025).

    Google Scholar 

  54. Nezafat, N. et al. Designing an efficient multi-epitope peptide vaccine against vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Comput. Biol. Chem. 62, 82–95. https://doi.org/10.1016/j.compbiolchem.2016.04.006 (2016).

    Google Scholar 

  55. Tsvetkov, P., Myers, N., Adler, J. & Shaul, Y. Degradation of intrinsically disordered proteins by the NADH 26S proteasome. Biomolecules 10, 1–10. https://doi.org/10.3390/BIOM10121642 (2020).

    Google Scholar 

  56. Hollingsworth, S. A. & Dror, R. O. Molecular dynamics simulation for all. Neuron 99, 1129. https://doi.org/10.1016/J.NEURON.2018.08.011 (2018).

    Google Scholar 

  57. Mallik, B. & Morikis, D. Applications of molecular dynamics simulations in immunology: A useful computational method in aiding vaccine design. Curr. Proteom. 3, 259–270. https://doi.org/10.2174/157016406780655568 (2007).

    Google Scholar 

  58. Troutman, T. D., Bazan, J. F. & Pasare, C. Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell. Cycle. 11, 3559. https://doi.org/10.4161/CC.21572 (2012).

    Google Scholar 

  59. Peters, B., Nielsen, M., Sette, A. T. & Cell Epitope Predictions Annu. Rev. Immunol. ;38:123. https://doi.org/10.1146/ANNUREV-IMMUNOL-082119-124838. (2020).

    Google Scholar 

Download references